Light-heavy chain deposition disease progressing to multiple myeloma

Area of Science:

• Nephrology
• Hematology
• Oncology

Background:

• Light chain deposition disease (LCDD) and light and heavy chain deposition disease (LHCDD) are rare renal disorders.
• These conditions are associated with monoclonal gammopathies, including multiple myeloma and monoclonal gammopathy of unknown significance (MGUS), or can occur idiopathically.
• Renal failure is a common complication, diagnosis is challenging, and long-term survival is infrequent.

Observation:

• This report details the first documented case of a patient with LHCDD and MGUS who later developed multiple myeloma.
• Disease progression was observed over an 11-year period.
• Key indicators of evolution included a rising monoclonal IgA immunoglobulin level, increased bone marrow plasmacytosis, and multiple bone marrow lesions identified via MRI.

Findings:

• The study presents a unique case of LHCDD and MGUS evolving into multiple myeloma.
• The documented progression underscores the potential for these rare deposition diseases to transform into active malignancy.
• Specific biomarkers and imaging findings indicated the shift from a premalignant state to overt multiple myeloma.

Implications:

• This case highlights the importance of long-term monitoring for patients diagnosed with LCDD or LHCDD, particularly those with associated monoclonal gammopathies.
• Understanding disease evolution pathways is crucial for timely diagnosis and management of multiple myeloma in this patient cohort.
• Further research into the mechanisms driving the progression of LCDD/LHCDD to multiple myeloma may improve patient outcomes and survival rates.